am 251 has been researched along with Cancer of Prostate in 3 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nithipatikom, K | 1 |
| Gomez-Granados, AD | 1 |
| Tang, AT | 1 |
| Pfeiffer, AW | 1 |
| Williams, CL | 1 |
| Campbell, WB | 1 |
| Ruiz, L | 2 |
| Miguel, A | 1 |
| Díaz-Laviada, I | 2 |
| Velasco, L | 1 |
| Sánchez, MG | 1 |
3 other studies available for am 251 and Cancer of Prostate
| Article | Year |
|---|---|
Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells.
Topics: Actins; Arachidonic Acids; Benzoxazines; Biological Transport, Active; cdc42 GTP-Binding Protein; Ce | 2012 |
Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism.
Topics: Annexin A5; Apoptosis; Benzoxazines; DNA Fragmentation; Dronabinol; Fluorescent Antibody Technique; | 1999 |
delta(9)-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells. Involvement of CB1 cannabinoid receptor and Raf-1.
Topics: Dose-Response Relationship, Drug; Dronabinol; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Huma | 2001 |